KMN-21

ID: ALA570176

Chembl Id: CHEMBL570176

PubChem CID: 45488001

Max Phase: Preclinical

Molecular Formula: C62H76N12O12

Molecular Weight: 1181.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: KMN-21 | CHEMBL570176|KMN-21

Canonical SMILES:  N=C(NCCCNC(=O)CNC(=O)CNC(=O)CCC(=O)NCC(=O)NCC(=O)N[C@H]1C[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5

Standard InChI:  InChI=1S/C62H76N12O12/c63-58(71-36-8-9-40-38(22-36)39-25-62(84)44-21-35-7-11-42(76)56-53(35)60(62,57(86-56)54(39)72-40)15-19-74(44)31-33-4-5-33)65-17-1-16-64-48(79)26-68-49(80)27-66-46(77)12-13-47(78)67-28-50(81)69-29-51(82)70-37-23-45-59-14-18-73(30-32-2-3-32)43(61(59,83)24-37)20-34-6-10-41(75)55(85-45)52(34)59/h6-11,22,32-33,37,43-45,57,72,75-76,83-84H,1-5,12-21,23-31H2,(H,64,79)(H,66,77)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H3,63,65,71)/t37-,43+,44+,45-,57-,59+,60-,61+,62+/m0/s1

Standard InChI Key:  UYMLPPZZDOFUGU-BXXSKVKHSA-N

Associated Targets(Human)

OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Opioid receptors; mu & kappa (822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1181.36Molecular Weight (Monoisotopic): 1180.5706AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhang S, Yekkirala A, Tang Y, Portoghese PS..  (2009)  A bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptors.,  19  (24): [PMID:19892550] [10.1016/j.bmcl.2009.10.045]

Source